Is WST Stock Undervalued At $200?
Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...
West Pharmaceutical forecasts 2025 results below expectations, shares drop
West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...
West Pharma’s stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of ...
This Pharma Stock Is Today’s Worst in the S&P 500. Here’s Why.
West Pharmaceutical Services stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations. Shares plunged 31% to $222.46, putting them on pace for their worst ...
West Pharmaceutical price target lowered to $285 from $355 at BofA
BofA lowered the firm’s price target on West Pharmaceutical (WST) to $285 from $355 and keeps a Buy rating on the shares after the company ...
West Pharmaceutical Services 4Q Results Clear Estimates but 2025 Guidance Comes Up Short
For 2025, West Pharmaceutical guided for sales between $2.88 billion and $2.91 billion as well as adjusted earnings per-share in the range of $6 and $6.20. Analysts polled by FactSet expected $3.04 ...
Yahoo Finance2d
West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings tomorrow morning. Here’s what to look for. West Pharmaceutical Services beat analysts’ revenue ...
West Pharma upgraded at Deutsche Bank despite earnings led selloff
Deutsche Bank upgraded West Pharmaceutical Services (NYSE:WST) to Buy from Hold on Friday, even after the contract drug manufacturer witnessed a ~38% drop in the previous session following a ...